Promises Made, Promises Kept The 2/28/2022 BIEL
Post# of 7805
(Total Views: 317)
Posted On: 07/07/2022 10:15:20 AM
Promises Made, Promises Kept
The 2/28/2022 BIEL Update closed with this paragraph:
"Finally, the Company is in discussions with three other research teams, two interested in studying wound care and the third studying pain reduction. This third study, which is out of the University of California, San Diego medical center, is already in the pilot stage and is looking at refractory phantom pain and total hip and knee pain. Such studies will continue to facilitate the Company’s goal of finding new applications and markets for its PSwT technology by highlighting the efficacy and safety of these applications via high quality studies that can be published in peer review medical journals."
Today we have this Case Report:
Treating Intractable Postamputation Pain with Noninvasive, Wearable, Nonthermal, Pulsed Shortwave (Radiofrequency) Therapy
BACKGROUND
Postamputation phantom and residual limb pain are common and frequently intractable, with few reliably effective treatments. Pulsed nonthermal shortwave (radiofrequency) electromagnetic field therapy is a noninvasive treatment used previously as an adjunct analgesic and wound healing therapy. Its use for postamputation pain remains unexamined.
CASE REPORT
Twelve patients with an above or below knee amputation with persistent, intractable phantom and/or residual limb pain unresponsive to multiple previous invasive treatments were provided with a noninvasive, wearable, pulsed electromagnetic field device (RecoveryRx, BioElectronics Corporation, Frederick, MD, USA). Patients used the included dressings to self-apply the 12 cm-diameter ringed antenna to their residual limb and then activated the device, which delivered nonthermal radiofrequency energy continuously for up to 30 days.
1 Department of Anesthesiology, University of California San Diego (UCSD),
San Diego, CA, USA
https://amjcaserep.com/abstract/index/idArt/937549
The 2/28/2022 BIEL Update closed with this paragraph:
"Finally, the Company is in discussions with three other research teams, two interested in studying wound care and the third studying pain reduction. This third study, which is out of the University of California, San Diego medical center, is already in the pilot stage and is looking at refractory phantom pain and total hip and knee pain. Such studies will continue to facilitate the Company’s goal of finding new applications and markets for its PSwT technology by highlighting the efficacy and safety of these applications via high quality studies that can be published in peer review medical journals."
Today we have this Case Report:
Treating Intractable Postamputation Pain with Noninvasive, Wearable, Nonthermal, Pulsed Shortwave (Radiofrequency) Therapy
BACKGROUND
Postamputation phantom and residual limb pain are common and frequently intractable, with few reliably effective treatments. Pulsed nonthermal shortwave (radiofrequency) electromagnetic field therapy is a noninvasive treatment used previously as an adjunct analgesic and wound healing therapy. Its use for postamputation pain remains unexamined.
CASE REPORT
Twelve patients with an above or below knee amputation with persistent, intractable phantom and/or residual limb pain unresponsive to multiple previous invasive treatments were provided with a noninvasive, wearable, pulsed electromagnetic field device (RecoveryRx, BioElectronics Corporation, Frederick, MD, USA). Patients used the included dressings to self-apply the 12 cm-diameter ringed antenna to their residual limb and then activated the device, which delivered nonthermal radiofrequency energy continuously for up to 30 days.
1 Department of Anesthesiology, University of California San Diego (UCSD),
San Diego, CA, USA
https://amjcaserep.com/abstract/index/idArt/937549
(3)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼